Identification and characterization of cancer stem cells in ovarian yolk sac tumors

Cancer Science

Volumn 101, Issue 10, 2010, Pages 2179-2185

  Suzuki, Shiro ^a   Terauchi, Mikio ^a   Umezu, Tomokazu ^a   Kajiyama, Hiroaki ^a   Shibata, Kiyosumi ^a   Nawa, Akihiro ^a   Kikkawa, Fumitaka ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; BETA1 INTEGRIN; GLYCOPROTEIN; HERMES ANTIGEN; LEUKOCYTE ANTIGEN; PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CANCER STEM CELL; CARCINOGENESIS; CELL GROWTH; CELL INVASION; CELL SURFACE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OVARY TUMOR; PRIORITY JOURNAL; YOLK SAC TUMOR; ANIMAL; BAGG ALBINO MOUSE; CELL PROLIFERATION; IMMUNOMAGNETIC SEPARATION; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD29; ANTIGENS, CD44; CELL LINE, TUMOR; CELL PROLIFERATION; ENDODERMAL SINUS TUMOR; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOMAGNETIC SEPARATION; MICE; MICE, INBRED BALB C; NEOPLASTIC STEM CELLS; OVARIAN NEOPLASMS; PEPTIDES;

EID: 77957067666     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01672.x     Document Type: Article

References (50)

1. Dallenbach P, Bonnefoi H, Pelte MF, Vlastos G. Yolk sac tumours of the ovary: an update. Eur J Surg Oncol 2006, 32:1063-75.
2. Nakashima N, Nagasaka T, Fukata S. Study of ovarian tumors treated at Nagoya University Hospital, 1965-1988. Gynecol Oncol 1990, 37:103-11.
3. Teilum G. Endodermal sinus tumors of the ovary and testis. Comparative morphogenesis of the so-called mesoephroma ovarii (Schiller) and extraembryonic (yolk sac-allantoic) structures of the rat's placenta. Cancer 1959, 12:1092-105.
4. Takashina T, Kanda Y, Hayakawa O, Kudo R, Ito E, Sagae S. Yolk sac tumors of the ovary and the human yolk sac. Am J Obstet Gynecol 1987, 156:223-9.
5. Talerman A, Haije WG, Baggerman L. Serum alphafetoprotein (AFP) in diagnosis and management of endodermal sinus (yolk sac) tumor and mixed germ cell tumor of the ovary. Cancer 1978, 41:272-8.
6. Mitchell PL, Al-Nasiri N, A'Hern R. Treatment of nondysgerminomatous ovarian germ cell tumors: an analysis of 69 cases. Cancer 1999, 85:2232-44.
7. Mayordomo JI, Paz-Ares L, Rivera F. Ovarian and extragonadal malignant germ-cell tumors in females: a single-institution experience with 43 patients. Ann Oncol 1994, 5:225-31.
8. Kawai M, Kano T, Furuhashi Y. Prognostic factors in yolk sac tumors of the ovary. A clinicopathologic analysis of 29 cases. Cancer 1991, 67:184-92.
9. Nawa A, Obata N, Kikkawa F. Prognostic factors of patients with yolk sac tumors of the ovary. Am J Obstet Gynecol 2001, 184:1182-8.
10. Presnell SC, Petersen B, Heidaran M. Stem cells in adult tissues. Semin Cell Dev Biol 2002, 13:369-76.
11. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-11.
12. Clarke MF, Dick JE, Dirks PB. Cancer stem cells - perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res 2006, 66:9339-44.
13. Shmelkov SV, St CR, Lyden D, Rafii S. AC133/CD133/Prominin-1. Int J Biochem Cell Biol 2005, 37:715-9.
14. Hemmati HD, Nakano I, Lazareff JA. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 2003, 100:15178-83.
15. Singh SK, Hawkins C, Clarke ID. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
16. Singh SK, Clarke ID, Terasaki M. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003, 63:5821-8.
17. Yuan X, Curtin J, Xiong Y. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 2004, 23:9392-400.
18. Bhatia M. AC133 expression in human stem cells. Leukemia 2001, 15:1685-8.
19. O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007, 445:106-10.
20. Ricci-Vitiani L, Lombardi DG, Pilozzi E. Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445:111-5.
21. Hermann PC, Huber SL, Herrler T. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007, 1:313-23.
22. Eramo A, Lotti F, Sette G. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 2008, 15:504-14.
23. Yin S, Li J, Hu C. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int J Cancer 2007, 120:1444-50.
24. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005, 65:10946-51.
25. Shibata K, Kajiyama H, Yamamoto E. Establishment and characterization of an ovarian yolk sac tumor cell line reveals possible involvement of Nkx2.5 in tumor development. Oncology 2008, 74:104-11.
26. Kajiyama H, Kikkawa F, Maeda O, Suzuki T, Ino K, Mizutani S. Increased expression of dipeptidyl peptidase IV in human mesothelial cells by malignant ascites from ovarian carcinoma patients. Oncology 2002, 63:158-65.
27. Kajiyama H, Kikkawa F, Khin E, Shibata K, Ino K, Mizutani S. Dipeptidyl peptidase IV overexpression induces up-regulation of E-cadherin and tissue inhibitors of matrix metalloproteinases, resulting in decreased invasive potential in ovarian carcinoma cells. Cancer Res 2003, 63:2278-83.
28. Ma S, Chan KW, Hu L. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 2007, 132:2542-56.
29. Baba T, Convery PA, Matsumura N. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells. Oncogene 2009, 28:209-18.
30. Loetscher P, Moser B, Baggiolini M. Chemokines and their receptors in lymphocyte traffic and HIV infection. Adv Immunol 2000, 74:127-80.
31. Burger JA, Kipps TJ. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 2006, 107:1761-7.
32. Kucia M, Reca R, Miekus K. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 2005, 23:879-94.
33. Zeelenberg IS, Ruuls-Van SL, Roos E. The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res 2003, 63:3833-9.
34. Muller A, Homey B, Soto H. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-6.
35. Kajiyama H, Shibata K, Terauchi M, Ino K, Nawa A, Kikkawa F. Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma. Int J Cancer 2008, 122:91-9.
36. Fuchs E, Tumbar T, Guasch G. Socializing with the neighbors: stem cells and their niche. Cell 2004, 116:769-78.
37. Moore KA, Lemischka IR. Stem cells and their niches. Science 2006, 311:1880-5.
38. Kiel MJ, Morrison SJ. Uncertainty in the niches that maintain haematopoietic stem cells. Nat Rev Immunol 2008, 8:290-301.
39. Petit I, Szyper-Kravitz M, Nagler A. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 2002, 3:687-94.
40. Sugiyama T, Kohara H, Noda M, Nagasawa T. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 2006, 25:977-88.
41. Jin L, Hope KJ, Zhai Q, Smadja-Joffe F, Dick JE. Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med 2006, 12:1167-74.
42. Looijenga LH, Stoop H, de LH. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 2003, 63:2244-50.
43. Scholer HR, Dressler GR, Balling R, Rohdewohld H, Gruss P. Oct-4: a germline-specific transcription factor mapping to the mouse t-complex. EMBO J 1990, 9:2185-95.
44. Okamoto K, Okazawa H, Okuda A, Sakai M, Muramatsu M, Hamada H. A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell 1990, 60:461-72.
45. Rosner MH, Vigano MA, Ozato K. A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature 1990, 345:686-92.
46. Pera MF, Herszfeld D. Differentiation of human pluripotent teratocarcinoma stem cells induced by bone morphogenetic protein-2. Reprod Fertil Dev 1998, 10:551-5.
47. Goto T, Adjaye J, Rodeck CH, Monk M. Identification of genes expressed in human primordial germ cells at the time of entry of the female germ line into meiosis. Mol Hum Reprod 1999, 5:851-60.
48. Hansis C, Grifo JA, Krey LC. Oct-4 expression in inner cell mass and trophectoderm of human blastocysts. Mol Hum Reprod 2000, 6:999-1004.
49. Pesce M, Wang X, Wolgemuth DJ, Scholer H. Differential expression of the Oct-4 transcription factor during mouse germ cell differentiation. Mech Dev 1998, 71:89-98.
50. Niwa H, Miyazaki J, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 2000, 24:372-6.